SIGA technologies’ TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses
On Jan. 2, 2025, SIGA Technologies announced that its antiviral treatment TEPOXX (tecovirimat 200 mg capsules), marketed as…
-
-
WHO experts gave Mpox virus variants new names
On Aug. 12, 2022, a group of global experts convened by WHO agreed on new names for monkeypox…
-
BD, CerTest Biotec announced commercial launch of Mpox test
On Jul. 27, 2022, BD (Becton, Dickinson) announced their newly developed molecular polymerase chain reaction (PCR) test for…
-
Quest Diagnostics launched Mpox virus testing
On Jul. 13, 2022, Quest Diagnostics announced that it had announced the nationwide availability of the company’s lab-developed…
-
Labcorp first national laboratory to offer Mpox test
On Jul. 6, 2022, LabCorp announced that it had begun testing for mpox using the U.S. Centers for…
-
Imported Mpox case reported in Maryland
On Nov. 17, 2021, scientists at the Centers for Disease Control and Prevention (CDC) announced they were collaborating…
-
SIGA announced collaboration with Oxford University to expanded Access Protocol for Use of TPOXX in Central African Republic
On Jul. 29, 2021, SIGA Technologies announced that it had entered into a collaboration with Oxford University in…
-
SIGA supplied TPOXX (Tecovirimat) as compassionate treatment for Mpox case in the UK
On Jul. 29, 2021, SIGA Technologies announced that it had entered into a collaboration with Oxford University in…
-
first human case of mpox Reported in the Democratic Republic of Congo
In 1970, the first cases of mpox were observed in the Democratic Republic of Congo, then spread to…
